Advertisement

Hormones

pp 1–11 | Cite as

The association between vitamin D status and infectious diseases of the respiratory system in infancy and childhood

  • Dimitra Zisi
  • Anna Challa
  • Alexandros MakisEmail author
Review Article

Abstract

Purpose

Respiratory tract infections (RTIs) are a major cause of illness worldwide and the most common cause of hospitalization for pneumonia and bronchiolitis. These two diseases are the leading causes of morbidity and mortality among children under 5 years of age. Vitamin D is believed to have immunomodulatory effects on the innate and adaptive immune systems by modulating the expression of antimicrobial peptides, like cathelicidin, in response to both viral and bacterial stimuli. The aim of this review is to summarize the more recently published data with regard to potential associations of 25-hydroxyvitamin D [25(OH)D] with infectious respiratory tract diseases of childhood and the possible health benefits from vitamin D supplementation.

Methods

The literature search was conducted by using the PubMed, Scopus, and Google Scholar databases, with the following keywords: vitamin D, respiratory tract infection, tuberculosis, influenza, infancy, and childhood.

Results

Several studies have identified links between inadequate 25(OH)D concentrations and the development of upper or lower respiratory tract infections in infants and young children. Some of them also suggest that intervention with vitamin D supplements could decrease both child morbidity and mortality from such causes.

Conclusions

Most studies agree in that decreased vitamin D concentrations are prevalent among most infants and children with RTIs. Also, normal to high-serum 25(OH)D appears to have some beneficial influence on the incidence and severity of some, but not all, types of these infections. However, studies with vitamin D supplementation revealed conflicting results as to whether supplementation may be of benefit, and at what doses.

Keywords

Vitamin D Infections Respiratory system Childhood 

Notes

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

References

  1. 1.
    Omar N, Mosaad Y (2017) Vitamin D and immune system. Vitam Miner 6:151Google Scholar
  2. 2.
    Deluca HF (2014) History of the discovery of vitamin D and its active metabolites. Bonekey Rep 3:479PubMedPubMedCentralGoogle Scholar
  3. 3.
    Esposito S, Lelii M (2015) Vitamin D and respiratory tract infections in childhood. BMC Infect Dis 15(1):487PubMedPubMedCentralCrossRefGoogle Scholar
  4. 4.
    Lemire JM (1995) Immunomodulatory actions of 1,25-dihydroxyvitamin D3. J Steroid Biochem Mol Biol 53(1-6):599–602PubMedCrossRefGoogle Scholar
  5. 5.
    van Etten E, Mathieu C (2005) Immunoregulation by 1,25-dihydroxyvitamin D3: basic concepts. J Steroid Biochem Mol Biol 97(1-2):93–101PubMedCrossRefGoogle Scholar
  6. 6.
    Bouillon R et al (1995) Paracrine role for calcitriol in the immune system and skin creates new therapeutic possibilities for vitamin D analogs. Eur J Endocrinol 133(1):7–16PubMedCrossRefGoogle Scholar
  7. 7.
    Huhtakangas JA et al (2004) The vitamin D receptor is present in caveolae-enriched plasma membranes and binds 1 alpha,25(OH)2-vitamin D3 in vivo and in vitro. Mol Endocrinol 18(11):2660–2671PubMedCrossRefGoogle Scholar
  8. 8.
    Norman AW, Ishizuka S, Okamura WH (2001) Ligands for the vitamin D endocrine system: different shapes function as agonists and antagonists for genomic and rapid response receptors or as a ligand for the plasma vitamin D binding protein. J Steroid Biochem Mol Biol 76(1-5):49–59PubMedCrossRefGoogle Scholar
  9. 9.
    Adams JS et al (1983) Metabolism of 25-hydroxyvitamin D3 by cultured pulmonary alveolar macrophages in sarcoidosis. J Clin Invest 72(5):1856–1860PubMedPubMedCentralCrossRefGoogle Scholar
  10. 10.
    Provvedini DM et al (1983) 1,25-dihydroxyvitamin D3 receptors in human leukocytes. Science 221(4616):1181–1183PubMedCrossRefGoogle Scholar
  11. 11.
    Rigby WF, Stacy T, Fanger MW (1984) Inhibition of T lymphocyte mitogenesis by 1,25-dihydroxyvitamin D3 (calcitriol). J Clin Invest 74(4):1451–1455PubMedPubMedCentralCrossRefGoogle Scholar
  12. 12.
    Zittermann A, Gummert JF (2010) Nonclassical vitamin D action. Nutrients 2(4):408–425PubMedPubMedCentralCrossRefGoogle Scholar
  13. 13.
    Gombart AF (2009) The vitamin D-antimicrobial peptide pathway and its role in protection against infection. Future Microbiol 4(9):1151–1165PubMedPubMedCentralCrossRefGoogle Scholar
  14. 14.
    Holick MF (2007) Vitamin D deficiency. N Engl J Med 357(3):266–281PubMedCrossRefGoogle Scholar
  15. 15.
    Holick MF et al (2011) Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 96(7):1911–1930PubMedCrossRefGoogle Scholar
  16. 16.
    IOM (2011) Dietary Reference intakes for calcium and vitamin D. The National Academies Press, Washington, DCGoogle Scholar
  17. 17.
    Pettifor JM (2013) Nutritional rickets: pathogenesis and prevention. Pediatr Endocrinol Rev 10(Suppl 2):347–353PubMedGoogle Scholar
  18. 18.
    Ross AC et al (2011) The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab 96(1):53–58PubMedCrossRefGoogle Scholar
  19. 19.
    Pludowski P et al (2018) Vitamin D supplementation guidelines. J Steroid Biochem Mol Biol 175:125–135PubMedCrossRefGoogle Scholar
  20. 20.
    Marchisio P et al (2013) Vitamin D supplementation reduces the risk of acute otitis media in otitis-prone children. Pediatr Infect Dis J 32(10):1055–1060PubMedCrossRefGoogle Scholar
  21. 21.
    Ginde AA, Mansbach JM, Camargo CA Jr (2009) Vitamin D, respiratory infections, and asthma. Curr Allergy Asthma Rep 9(1):81–87PubMedCrossRefGoogle Scholar
  22. 22.
    Wang TT et al (2004) Cutting edge: 1,25-dihydroxyvitamin D3 is a direct inducer of antimicrobial peptide gene expression. J Immunol 173(5):2909–2912PubMedCrossRefGoogle Scholar
  23. 23.
    Gallo RL et al (2002) Biology and clinical relevance of naturally occurring antimicrobial peptides. J Allergy Clin Immunol 110(6):823–831PubMedCrossRefGoogle Scholar
  24. 24.
    Adams JS, Hewison M (2008) Unexpected actions of vitamin D: new perspectives on the regulation of innate and adaptive immunity. Nat Clin Pract Endocrinol Metab 4(2):80–90PubMedPubMedCentralCrossRefGoogle Scholar
  25. 25.
    Lai Y, Gallo RL (2009) AMPed Up immunity: how antimicrobial peptides have multiple roles in immune defense. Trends Immunol 30(3):131–141PubMedPubMedCentralCrossRefGoogle Scholar
  26. 26.
    Liu PT et al (2006) Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 311(5768):1770–1773PubMedCrossRefGoogle Scholar
  27. 27.
    Liu PT et al (2009) Convergence of IL-1beta and VDR activation pathways in human TLR2/1-induced antimicrobial responses. PLoS One 4(6):e5810PubMedPubMedCentralCrossRefGoogle Scholar
  28. 28.
    Hewison M (2012) Vitamin D and the immune system: new perspectives on an old theme. Rheum Dis Clin N Am 38(1):125–139CrossRefGoogle Scholar
  29. 29.
    Adams JS et al (2014) Regulation of the extrarenal CYP27B1-hydroxylase. J Steroid Biochem Mol Biol 144(Pt A):22–27PubMedCrossRefGoogle Scholar
  30. 30.
    Di Rosa M et al (2011) Vitamin D3: a helpful immuno-modulator. Immunology 134(2):123–139PubMedPubMedCentralCrossRefGoogle Scholar
  31. 31.
    Topilski I et al (2004) The anti-inflammatory effects of 1,25-dihydroxyvitamin D3 on Th2 cells in vivo are due in part to the control of integrin-mediated T lymphocyte homing. Eur J Immunol 34(4):1068–1076PubMedCrossRefGoogle Scholar
  32. 32.
    Mahon BD et al (2003) The targets of vitamin D depend on the differentiation and activation status of CD4 positive T cells. J Cell Biochem 89(5):922–932PubMedCrossRefGoogle Scholar
  33. 33.
    Chen S et al (2007) Modulatory effects of 1,25-dihydroxyvitamin D3 on human B cell differentiation. J Immunol 179(3):1634–1647PubMedCrossRefGoogle Scholar
  34. 34.
    Williams B, Williams AJ, Anderson ST (2008) Vitamin D deficiency and insufficiency in children with tuberculosis. Pediatr Infect Dis J 27(10):941–942PubMedCrossRefGoogle Scholar
  35. 35.
    Gray K et al (2012) Vitamin d and tuberculosis status in refugee children. Pediatr Infect Dis J 31(5):521–523PubMedCrossRefGoogle Scholar
  36. 36.
    Venturini E et al (2014) Vitamin D and tuberculosis: a multicenter study in children. BMC Infect Dis 14:652PubMedPubMedCentralCrossRefGoogle Scholar
  37. 37.
    Agarwal A et al (2015) Vitamin D status in pediatric osteoarticular tuberculosis. J Clin Orthop Trauma 6(4):227–229PubMedPubMedCentralCrossRefGoogle Scholar
  38. 38.
    Dabla PK et al (2016) Vitamin D deficiency among pediatric osteoarticular tuberculosis patients. J Clin Orthop Trauma 7(Suppl 2):147–149PubMedPubMedCentralCrossRefGoogle Scholar
  39. 39.
    Khandelwal D et al (2014) Vitamin D levels in Indian children with intrathoracic tuberculosis. Indian J Med Res 140(4):531–537PubMedPubMedCentralGoogle Scholar
  40. 40.
    Buonsenso D et al (2018) Vitamin D levels in active TB, latent TB, non-TB pneumonia and healthy children: a prospective observational study. Fetal Pediatr Pathol:1–11Google Scholar
  41. 41.
    Jubulis J et al (2014) Modifiable risk factors associated with tuberculosis disease in children in Pune. India Int J Tuberc Lung Dis 18(2):198–204PubMedCrossRefGoogle Scholar
  42. 42.
    Ludmir J et al (2016) Vitamin D status in Botswana children under 2 years old with and without active tuberculosis. Am J Trop Med Hyg 94(5):971–974PubMedPubMedCentralCrossRefGoogle Scholar
  43. 43.
    WHO (2013) W.H.O., Global tuberculosis report 2013. https://apps.who.int/iris/handle/10665/91355
  44. 44.
    Ganmaa D et al (2018) Prevalence and determinants of QuantiFERON-diagnosed tuberculosis infection in 9810 Mongolian schoolchildren. Clin Infect Dis 69(5):813–819CrossRefGoogle Scholar
  45. 45.
    Morcos MM et al (1998) Vitamin D administration to tuberculous children and its value. Boll Chim Farm 137(5):157–164PubMedGoogle Scholar
  46. 46.
    Ganmaa D et al (2012) Vitamin D, tuberculin skin test conversion, and latent tuberculosis in Mongolian school-age children: a randomized, double-blind, placebo-controlled feasibility trial. Am J Clin Nutr 96(2):391–396PubMedPubMedCentralCrossRefGoogle Scholar
  47. 47.
    Marchisio P et al (2014) Medical prevention of recurrent acute otitis media: an updated overview. Expert Rev Anti-Infect Ther 12(5):611–620PubMedCrossRefGoogle Scholar
  48. 48.
    Li HB et al (2016) Association between vitamin D and development of otitis media: a PRISMA-compliant meta-analysis and systematic review. Medicine (Baltimore) 95(40):e4739CrossRefGoogle Scholar
  49. 49.
    Cayir A et al (2014) Vitamin D levels in children diagnosed with acute otitis media. J Pak Med Assoc 64(11):1274–1277PubMedGoogle Scholar
  50. 50.
    Hosseini S et al (2016) Vitamin D levels in children with otitis media with effusion: a case-control study. Thrita 5(1):e31977CrossRefGoogle Scholar
  51. 51.
    Asghari A et al (2017) Vitamin D levels in children with adenotonsillar hypertrophy and otitis media with effusion. Iran J Otorhinolaryngol 29(90):29–33PubMedPubMedCentralGoogle Scholar
  52. 52.
    Walker RE et al (2017) Higher serum 25(OH)D concentration is associated with lower risk of chronic otitis media with effusion: a case-control study. Acta Paediatr 106(9):1487–1492PubMedCrossRefGoogle Scholar
  53. 53.
    Akcan FA et al (2018) Clinical role of vitamin D in prognosis of otitis media with effusion. Int J Pediatr Otorhinolaryngol 105:1–5PubMedCrossRefGoogle Scholar
  54. 54.
    Elemraid MA et al (2011) A case-control study of nutritional factors associated with chronic suppurative otitis media in Yemeni children. Eur J Clin Nutr 65(8):895–902PubMedCrossRefGoogle Scholar
  55. 55.
    Cayir A et al (2014) Serum vitamin D levels in children with recurrent otitis media. Eur Arch Otorhinolaryngol 271(4):689–693PubMedCrossRefGoogle Scholar
  56. 56.
    Bisno AL (1996) Acute pharyngitis: etiology and diagnosis. Pediatrics 97(6 Pt 2):949–954PubMedGoogle Scholar
  57. 57.
    Paradise JL et al (2002) Tonsillectomy and adenotonsillectomy for recurrent throat infection in moderately affected children. Pediatrics 110(1 Pt 1):7–15PubMedCrossRefGoogle Scholar
  58. 58.
    Reid D et al (2011) Vitamin D and tonsil disease--preliminary observations. Int J Pediatr Otorhinolaryngol 75(2):261–264PubMedCrossRefGoogle Scholar
  59. 59.
    Yildiz I et al (2012) The role of vitamin D in children with recurrent tonsillopharyngitis. Ital J Pediatr 38:25PubMedPubMedCentralCrossRefGoogle Scholar
  60. 60.
    Elbistanlı MS et al (2017) Relationship between serum vitamin D levels and childhood recurrent tonsillitis. Otolaryngol Open J 3(1):16–21CrossRefGoogle Scholar
  61. 61.
    Aydin S et al (2011) Vitamin D levels in children with recurrent tonsillitis. Int J Pediatr Otorhinolaryngol 75(3):364–367PubMedCrossRefGoogle Scholar
  62. 62.
    Nocon CC, Baroody FM (2014) Acute rhinosinusitis in children. Curr Allergy Asthma Rep 14(6):443PubMedCrossRefGoogle Scholar
  63. 63.
    Bhattacharyya N (2001) Chronic rhinosinusitis: is the nose really involved? Am J Rhinol 15(3):169–173PubMedCrossRefGoogle Scholar
  64. 64.
    Mulligan JK et al (2012) Vitamin D3 deficiency increases sinus mucosa dendritic cells in pediatric chronic rhinosinusitis with nasal polyps. Otolaryngol Head Neck Surg 147(4):773–781PubMedCrossRefGoogle Scholar
  65. 65.
    Elbistanlı MS et al (2017) Vit D deficiency is a possible risk factor in ARS. Eur Arch Otorhinolaryngol 274(9):3391–3395PubMedCrossRefGoogle Scholar
  66. 66.
    Yosef H (2016) Saeed Abdelkarim, Agila Al-Barasi, and E.S. Hussien, Effect of vitamin-D supplement in patients diagnosed as chronic rhinosinusitis with vitamin-D deficiency. Int J Otorhinolaryngol 2(1):1–4CrossRefGoogle Scholar
  67. 67.
    Gong W et al (2014) Effect of nasal instillation of vitamin D3 on patient with allergic rhinitis symptoms. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 28(14):1031–1033PubMedGoogle Scholar
  68. 68.
    Linday LA, Dolitsky JN, Shindledecker RD (2004) Nutritional supplements as adjunctive therapy for children with chronic/recurrent sinusitis: pilot research. Int J Pediatr Otorhinolaryngol 68(6):785–793PubMedCrossRefGoogle Scholar
  69. 69.
    Pavia AT (2011) Viral infections of the lower respiratory tract: old viruses, new viruses, and the role of diagnosis. Clin Infect Dis 52(Suppl 4):S284–S289PubMedPubMedCentralCrossRefGoogle Scholar
  70. 70.
    Larkin A, Lassetter J (2014) Vitamin D deficiency and acute lower respiratory infections in children younger than 5 years: identification and treatment. J Pediatr Health Care 28(6):572–582 quiz 583-4PubMedCrossRefGoogle Scholar
  71. 71.
    Karatekin G et al (2009) Association of subclinical vitamin D deficiency in newborns with acute lower respiratory infection and their mothers. Eur J Clin Nutr 63(4):473–477PubMedCrossRefGoogle Scholar
  72. 72.
    Roth DE et al (2010) Vitamin D status and acute lower respiratory infection in early childhood in Sylhet, Bangladesh. Acta Paediatr 99(3):389–393PubMedCrossRefGoogle Scholar
  73. 73.
    Singh Narang G et al (2016) Association of vitamin D deficiency with acute lower respiratory infection in toddlers. J Nepal Paediatr Soc 36:14CrossRefGoogle Scholar
  74. 74.
    McNally JD et al (2009) Vitamin D deficiency in young children with severe acute lower respiratory infection. Pediatr Pulmonol 44(10):981–988PubMedCrossRefGoogle Scholar
  75. 75.
    Sismanlar T et al (2016) The effect of vitamin D on lower respiratory tract infections in children. Turk Pediatri Ars 51(2):94–99PubMedPubMedCentralCrossRefGoogle Scholar
  76. 76.
    Mahyar A et al (2017) Evaluation of serum 25-hydroxy vitamin D levels in children with acute bronchiolitis. Arch Pediatr Infect Dis 5(2):e39477Google Scholar
  77. 77.
    Roth DE et al (2009) Vitamin D status is not associated with the risk of hospitalization for acute bronchiolitis in early childhood. Eur J Clin Nutr 63(2):297–299PubMedCrossRefGoogle Scholar
  78. 78.
    Inamo Y et al (2011) Serum vitamin D concentrations and associated severity of acute lower respiratory tract infections in Japanese hospitalized children. Pediatr Int 53(2):199–201PubMedCrossRefGoogle Scholar
  79. 79.
    Dinlen N et al (2016) Association of vitamin D deficiency with acute lower respiratory tract infections in newborns. J Matern Fetal Neonatal Med 29(6):928–932PubMedCrossRefGoogle Scholar
  80. 80.
    Meltem E et al (2017) The effect of vitamin D deficiency on the severity of bronchiolitis in infants. J Pediatr Res 4:12–16CrossRefGoogle Scholar
  81. 81.
    Leis KS et al (2012) Vitamin D intake in young children with acute lower respiratory infection. Transl Pediatr 1(1):6–14PubMedPubMedCentralGoogle Scholar
  82. 82.
    Saad K et al (2015) Trial of vitamin D supplementation in infants with bronchiolitis: a randomized, double-blind, placebo-controlled study. Pediatr Allergy Immunol Pulmonol 28(2):102–106CrossRefGoogle Scholar
  83. 83.
    Manaseki-Holland S et al (2010) Effects of vitamin D supplementation to children diagnosed with pneumonia in Kabul: a randomised controlled trial. Tropical Med Int Health 15(10):1148–1155CrossRefGoogle Scholar
  84. 84.
    Manaseki-Holland S et al (2012) Effect on the incidence of pneumonia of vitamin D supplementation by quarterly bolus dose to infants in Kabul: a randomised controlled superiority trial. Lancet 379(9824):1419–1427PubMedPubMedCentralCrossRefGoogle Scholar
  85. 85.
    Choudhary N, Gupta P (2012) Vitamin D supplementation for severe pneumonia--a randomized controlled trial. Indian Pediatr 49(6):449–454PubMedCrossRefGoogle Scholar
  86. 86.
    Gupta P et al (2016) Vitamin D supplementation for treatment and prevention of pneumonia in under-five children: a randomized double-blind placebo controlled trial. Indian Pediatr 53(11):967–976PubMedCrossRefGoogle Scholar
  87. 87.
    Belderbos ME et al (2011) Cord blood vitamin D deficiency is associated with respiratory syncytial virus bronchiolitis. Pediatrics 127(6):e1513–e1520PubMedCrossRefGoogle Scholar
  88. 88.
    Mohamed WA, Al-Shehri MA (2013) Cord blood 25-hydroxyvitamin D levels and the risk of acute lower respiratory tract infection in early childhood. J Trop Pediatr 59(1):29–35PubMedCrossRefGoogle Scholar
  89. 89.
    Luczynska A et al (2014) Cord blood 25(OH)D levels and the subsequent risk of lower respiratory tract infections in early childhood: the Ulm birth cohort. Eur J Epidemiol 29(8):585–594PubMedCrossRefGoogle Scholar
  90. 90.
    Lai SH et al (2017) Low cord-serum 25-hydroxyvitamin D levels are associated with poor lung function performance and increased respiratory infection in infancy. PLoS One 12(3):e0173268PubMedPubMedCentralCrossRefGoogle Scholar
  91. 91.
    Urashima M et al (2010) Randomized trial of vitamin D supplementation to prevent seasonal influenza A in schoolchildren. Am J Clin Nutr 91(5):1255–1260PubMedCrossRefGoogle Scholar
  92. 92.
    Zhou J et al (2018) Preventive effects of vitamin D on seasonal influenza A in infants: a multicenter, randomized, open, controlled clinical trial. Pediatr Infect Dis J 37(8):749–754PubMedCrossRefGoogle Scholar
  93. 93.
    Aglipay M et al (2017) Effect of High-dose vs standard-dose wintertime vitamin d supplementation on viral upper respiratory tract infections in young healthy children. Jama 318(3):245–254PubMedPubMedCentralCrossRefGoogle Scholar
  94. 94.
    Camargo CA Jr et al (2012) Randomized trial of vitamin D supplementation and risk of acute respiratory infection in Mongolia. Pediatrics 130(3):e561–e567PubMedCrossRefGoogle Scholar

Copyright information

© Hellenic Endocrine Society 2019

Authors and Affiliations

  1. 1.Child Health Department, Faculty of MedicineUniversity of IoanninaIoanninaGreece

Personalised recommendations